IONIS PHARMACEUTICALS INC Logo

IONIS PHARMACEUTICALS INC

A leader in antisense technology, developing RNA-targeted drugs for neurology and cardiology.

IONS | US

Overview

Corporate Details

ISIN(s):
US4622221004
LEI:
Country:
United States of America
Address:
2855 GAZELLE COURT, 92010 CARLSBAD
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Ionis Pharmaceuticals, Inc. is a biotechnology company focused on discovering and developing RNA-targeted therapeutics. A leader in antisense technology, the company utilizes its proprietary science and chemistry platform to create medicines that treat a wide range of serious diseases. Ionis maintains a robust pipeline and has several marketed products targeting conditions in neurology, cardiology, and other areas of high unmet patient need. The company's core mission is to leverage its deep understanding of genetics to deliver innovative treatments that can change the course of human health for patients and their families.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all IONIS PHARMACEUTICALS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IONIS PHARMACEUTICALS INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IONIS PHARMACEUTICALS INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Intellia Therapeutics, Inc. Logo
Developing curative CRISPR/Cas9 genome editing therapies for severe genetic disorders.
United States of America NTLA
Intercure Ltd. Logo
Develops and distributes pharmaceutical-grade medical cannabis for patients and pharmacies globally.
Israel INCR
Intercure Ltd. Logo
A leading producer of pharmaceutical-grade, GMP-certified medical cannabis products.
United States of America INCR
Intervacc AB Logo
Develops recombinant protein vaccines and diagnostics for animal health, like Strangvac® for horses.
Sweden IVACC
iNtRON Biotechnology, Inc. Logo
Develops phage therapeutics and molecular diagnostics to combat infectious diseases.
South Korea 048530
Inventage Lab Inc. Logo
Develops drug delivery systems using microfluidics for chronic diseases and gene therapies.
South Korea 389470
Inventiva S.A. Logo
Develops oral small molecule therapies for NASH, fibrosis, and rare metabolic disorders.
United States of America IVA
Invivyd, Inc. Logo
Develops evolution-resistant antibodies to protect against viral diseases like COVID-19 and flu.
United States of America IVVD
IO Biotech, Inc. Logo
Develops dual-action, off-the-shelf therapeutic cancer vaccines for solid tumors.
United States of America IOBT
IOVANCE BIOTHERAPEUTICS, INC. Logo
Developing personalized T-cell immunotherapies (TIL) to fight solid tumors and blood cancers.
United States of America IOVA

Talk to a Data Expert

Have a question? We'll get back to you promptly.